SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...

Surgery might be unnecessary for patients with low-grade ductal carcinoma in situ (DCIS). Instead, they could be managed with active surveillance. That bombshell conclusion comes from a retrospective ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DURHAM, N.C. (WNCN) — A Duke Researcher’s ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens. One new study, published in the New England Journal of ...

The 43-year-old stressed that her cancer was caught “very, very, very early,” adding that she’s going to be okay. Danielle also credited getting a yearly mammogram with helping her cancer to be ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

A new LOCAL online community built for you. Click now to see all the available groups. The hormone therapy tamoxifen can keep cancer from recurring in women with DCIS Tamoxifen following lumpectomy ...

Women with certain types of breast cancer may be able to avoid the mental and physical burden of surgery, according to two new studies. Some early breast cancer patients can safely avoid specific ...